Porcine circovirus type 2 (PCV2) infection decreases the efficacy of an attenuated classical swine fever virus (CSFV) vaccine
The aim of this study was to investigate whether PCV2 infection affects the efficacy of the LPC vaccine.
Page 14 of articles about vaccine
PRRS Immunology
Resolving the basis of viral and host variation will require identification and characterization of key B- and T-cell epitopes conserved among diverse PRRSV, and of the molecular and structural details of key effector antibodies, T-cell antigen receptors, and MHC molecules that mediate broad, cross-protective immunity.
Mycoplasma hyorhinis - not just a commensal
Although a commensal, M. hyorhinis may cause serious systemic disease through mechanisms that are not fully understood.
Vaccination of sows reduces the prevalence of PCV-2 viraemia in their piglets under field conditions
Under the study conditions, dam vaccination reduced PCV-2 viraemia in the offspring with colostrum access.
Novel cell line identifies all Foot-and-Mouth virus serotypes
The new cells detect the FMD virus in field samples that come directly from naturally infected animals faster than existing cell lines currently used for diagnostics.
Impact of genetic variation and geographic distribution of PRRSV on infectivity and pig growth
The PRRSV genetic variability which is determined by a local and temporal evolution at the farm level could be considered in a perspective of prevention.
Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection
The present study characterized the homologous and heterologous immune response in type-I porcine reproductive and respiratory syndrome virus (PRRSV) infection.
1
NewsA new methodology to produce a vaccine for foot-and-mouth disease
The vaccine is all synthetic, made up of tiny protein shells designed to trigger optimum immune response.
United States donates one million doses of Classical Swine Fever vaccine to Guatemala
On March 19, APHIS donated the vaccines based on a request for assistance from the Guatemalan Chief Veterinary Officer, Dr. Humberto Maldonado, to help Guatemala control the spread of CSF there.
Protective effect of the maternally derived porcine circovirus type 2 (PCV2)-specific cellular immune response in piglets by dam vaccination against PCV2 challenge
Maternally derived adaptive cellular immune responses play a critical role in protecting newborn piglets challenging PCV2 at 3 weeks of age.
Emergency vaccination alleviates highly pathogenic porcine reproductive and respiratory syndrome virus infection after contact exposure
These results indicated that emergency vaccination could effectively alleviate HPPRRSV infection during experimental contact exposure.
Preventing disease: One billion pigs vaccinated with Ingelvac CircoFLEX®
Veterinarians and farmers across the globe have reached the landmark of protecting one billion pigs from the potentially devastating effects of Porcine Circovirus Disease (PCVD) using Ingelvac CircoFLEX®
New edema vaccine licensed in Switzerland
Ecoporc Shiga induces a high level of immunity against shigatoxin, produced by E coli bacteria which cause edema.
Effect of sow and piglet porcine circovirus type 2 (PCV2) vaccination on piglet mortality, viraemia, antibody titre and production parameters
PCV2 vaccination was able to overcome this interference since the ADWG was improved.
It’s not too late to get a flu vaccination
As flu season swings into full gear, producers and those who work with pigs are reminded that it’s not too late to get a seasonal flu vaccination.
Harrisvaccines to develop FMD vaccine
The U.S. Department of Homeland Security has awarded Harrisvaccines a $1 million-plus contract to develop a vaccine for foot-and-mouth disease, one of the world’s most economically devastating animal diseases.